ACLY and rheumatoid arthritis: RBM25 modulates the exclusion of exon 14 from ATP citrate lyase (Acly) in a manner reliant on protein lactylation modification (K918/995 sites), altering the glycolytic response and inflammatory gene transcription programme of macrophages, therefore impacting the progression of RA disease.140